Alvaro Danza

Montevideo, MO, Uruguay

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Luminescence-guided engineering of anti-idiotype nanobody-NanoLuc fusion reagents for sensitive monitoring of free therapeutic antibodies.

Luminescence-guided engineering of anti-idiotype nanobody-NanoLuc fusion reagents for sensitive monitoring of free therapeutic antibodies.

Journal: Talanta

Published: April 29, 2026

Treatment patterns and outcomes of first lupus nephritis episode over 25 years in two Latin American cohorts.

Treatment patterns and outcomes of first lupus nephritis episode over 25 years in two Latin American cohorts.

Journal: Lupus

Published: April 28, 2026

Baseline characteristics of patients with SLE with and without lupus nephritis from the Latin American multiethnic GLADEL 2.0 cohort.

Baseline characteristics of patients with SLE with and without lupus nephritis from the Latin American multiethnic GLADEL 2.0 cohort.

Journal: Lupus science & medicine

Published: November 05, 2025

Delays in Lupus Diagnosis and Treatment in the Southern Cone: A Qualitative Study of Patient and Rheumatologist Perspectives.

Delays in Lupus Diagnosis and Treatment in the Southern Cone: A Qualitative Study of Patient and Rheumatologist Perspectives.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: August 23, 2025

Delays in Lupus Diagnosis and Treatment in the Southern Cone: A Qualitative Study of Patient and Rheumatologist Perspectives.

Delays in Lupus Diagnosis and Treatment in the Southern Cone: A Qualitative Study of Patient and Rheumatologist Perspectives.

Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases

Published: August 23, 2025

Cross Cultural Validation of Work Productivity and Activity Impairment Questionnaire in Lupus Patients From Latin America.

Cross Cultural Validation of Work Productivity and Activity Impairment Questionnaire in Lupus Patients From Latin America.

Journal: International journal of rheumatic diseases

Published: August 22, 2025

Progenitor cells and circulating endothelial cells are associated with disease activity and damage in systemic lupus erythematosus patients.

Progenitor cells and circulating endothelial cells are associated with disease activity and damage in systemic lupus erythematosus patients.

Journal: Lupus

Published: March 25, 2025

Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries.

Prevalence and target attainment of traditional cardiovascular risk factors in patients with systemic lupus erythematosus: a cross-sectional study including 3401 individuals from 24 countries.

Journal: The Lancet. Rheumatology

Published: February 18, 2024

Prednisone and long-term damage in systemic lupus erythematosus: Which is the threshold dose? A pilot study.

Prednisone and long-term damage in systemic lupus erythematosus: Which is the threshold dose? A pilot study.

Journal: Lupus

Published: March 30, 2022

Off-label use of mycophenolate mofetil in immune-mediated diseases

Off-label use of mycophenolate mofetil in immune-mediated diseases

Journal: Revista medica de Chile

Published: July 05, 2021

Glucocorticoids in Systemic Lupus Erythematosus. Ten Questions and Some Issues.

Glucocorticoids in Systemic Lupus Erythematosus. Ten Questions and Some Issues.

Journal: Journal of clinical medicine

Published: July 09, 2020

Glucocorticoids and antimalarials in systemic lupus erythematosus: an update and future directions.

Glucocorticoids and antimalarials in systemic lupus erythematosus: an update and future directions.

Journal: Current opinion in rheumatology

Published: June 06, 2018

Showing 1-12 of 22

Last Updated: 09/26/2026